Borosil Scientific Ltd

Borosil Scientific Ltd

₹ 178 -0.76%
13 Dec - close price
About

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]

Key Points

Borosil Group[1]
The company is a part of Borosil group which is into glassware and laboratory products,
scientific & industrial glassware, consumer & kitchenware products, and solar glass products. Group comprises of:
1. Borosil Renewables Ltd
2. Borosil Ltd
3. Borosil Scientific Ltd

  • Market Cap 1,581 Cr.
  • Current Price 178
  • High / Low 230 / 137
  • Stock P/E 54.9
  • Book Value 44.0
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value 1.00

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 4.05 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
87.54 91.97 99.68 115.39 104.20 102.61
81.82 82.50 87.53 97.44 94.37 87.16
Operating Profit 5.72 9.47 12.15 17.95 9.83 15.45
OPM % 6.53% 10.30% 12.19% 15.56% 9.43% 15.06%
1.11 1.44 1.06 1.80 2.16 1.95
Interest 0.76 0.73 0.54 0.67 0.40 0.36
Depreciation 3.65 3.85 4.50 4.45 4.57 4.63
Profit before tax 2.42 6.33 8.17 14.63 7.02 12.41
Tax % -35.54% 20.22% 30.48% 35.27% 28.49% 29.09%
3.29 5.05 5.69 9.46 5.03 8.80
EPS in Rs 0.65 1.05 0.57 0.99
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 TTM
390 422
345 366
Operating Profit 45 55
OPM % 12% 13%
5 7
Interest 3 2
Depreciation 16 18
Profit before tax 32 42
Tax % 26%
23 29
EPS in Rs 2.65 3.26
Dividend Payout % 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Sep 2024
Equity Capital 9 9
Reserves 367 382
18 18
95 82
Total Liabilities 488 490
192 185
CWIP 1 4
Investments 0 6
295 295
Total Assets 488 490

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024
30
-2
-16
Net Cash Flow 12

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024
Debtor Days 57
Inventory Days 244
Days Payable 102
Cash Conversion Cycle 200
Working Capital Days 177
ROCE %

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024
67.92% 67.86%
0.38% 0.37%
0.15% 0.01%
31.54% 31.74%
No. of Shareholders 62,35461,201

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents